AAIC 2025 Abstract
Evaluating AR1001 as Monotherapy from a Phase 2 Study in Mild to Moderate Alzheimer’s Disease Patients
Trial in peopleInterventions
Papers by Fred Kim
3 results
- AAIC 2025 Abstract
Multiple Beneficial Effects of AR1001 on Aβ‐Induced Changes in Human Minibrain
Experiments in cellsInterventions